Heather Knight - Mar 1, 2023 Form 3/A Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
EVP, Group Pres, Med Products
Signature
/s/ Matthew Rice, as attorney in-fact for Heather Knight
Stock symbol
BAX
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
3/A
Date filed
2/14/2024, 04:58 PM
Date Of Original Report
Mar 3, 2023
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BAX Common Stock, $1 par value 34.1K Mar 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on March 3, 2023, which inadvertently reported 33,011 shares of Baxter common stock beneficially owned by the reporting person instead of the 34,132 shares reported herein.